The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding

Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00506-2 · Cited by 1,369

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag

VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., & Carter, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131059198 · Cited by 584

Role of ESCRT-I in Retroviral Budding

Martin-Serrano, J., Zang, T., & Bieniasz, P. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4794-4804.2003 · Cited by 250

APOBECs and virus restriction

Harris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551

Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G

Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485

Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway

Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., & Gabuzda, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313093200 · Cited by 474

Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication

Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435

DNA glycosylases: In DNA repair and beyond

Jacobs, A. L., & Schär, P. (2012) · Chromosoma · doi:10.1007/s00412-011-0347-4 · Cited by 407

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

Jäger, S., Kim, D. Y., Hultquist, J. F., Shindo, K., LaRue, R. S., Kwon, E., Li, M., Anderson, B. D., Yen, L., Stanley, D., et al. (2012) · Nature · doi:10.1038/nature10693 · Cited by 352

The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities

Keckesova, Z., Ylinen, L. M. J., & Towers, G. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402474101 · Cited by 344

Complementary function of the two catalytic domains of APOBEC3G

Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 305

Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous Retroviruses

Denner, J., & Tönjes, R. R. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05011-11 · Cited by 208

Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif

Guo, Y., Dong, L., Qiu, X., Wang, Y., Zhang, B., Liu, H., Yu, Y., Zang, Y., Yang, M., & Huang, Z. (2014) · Nature · doi:10.1038/nature12884 · Cited by 202

APOBEC Enzymes as Targets for Virus and Cancer Therapy

Olson, M. E., Harris, R. S., & Harki, D. A. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.10.007 · Cited by 164

HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system

DeHart, J. L., Zimmerman, E. S., Ardon, O., Monteiro-Filho, C. M., Argañaraz, E. R., & Planelles, V. (2007) · Virology Journal · doi:10.1186/1743-422x-4-57 · Cited by 152

T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection

Garrison, K. E., Jones, R. B., Meiklejohn, D. A., Anwar, N., Ndhlovu, L. C., Chapman, J. M., Erickson, A. L., Agrawal, A., Spotts, G., Hecht, F. M., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030165 · Cited by 131

APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo

Fan, J., Ma, G., Nosaka, K., Tanabe, J., Satou, Y., Koito, A., Wain-Hobson, S., Vartanian, J.-P., & Matsuoka, M. (2010) · Journal of Virology · doi:10.1128/jvi.02239-09 · Cited by 130

Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution

Ratcliff, J., & Simmonds, P. (2021) · Virology · doi:10.1016/j.virol.2020.12.018 · Cited by 108

Role of viral regulatory and accessory proteins in HIV-1 replication

Seelamgari, A. (2004) · Frontiers in Bioscience · doi:10.2741/1403 · Cited by 98

Multifaceted antiviral actions of APOBEC3 cytidine deaminases

Chiu, Y.-L., & Greene, W. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.003 · Cited by 72

Vpr and Vpu Are Important for Efficient Human Immunodeficiency Virus Type 1 Replication and CD4 + T-Cell Depletion in Human Lymphoid Tissue Ex Vivo

Rücker, E., Grivel, J.-C., Münch, J., Kirchhoff, F., & Margolis, L. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12689-12693.2004 · Cited by 48

Evidence for Restriction of Ancient Primate Gammaretroviruses by APOBEC3 but Not TRIM5α Proteins

Perez-Caballero, D., Soll, S. J., & Bieniasz, P. D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000181 · Cited by 45

The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA

Keating, C. P., Hill, M. K., Hawkes, D. J., Smyth, R. P., Isel, C., Le, S.-Y., Palmenberg, A. C., Marshall, J. A., Marquet, R., Nabel, G. J., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1015 · Cited by 35

A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth

Pan, T., Zhang, Y., Zhou, N., He, X., Chen, C., Liang, L., Duan, X., Lin, Y., Wu, K., & Zhang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9996 · Cited by 21

Noncoding RNAs in Retrovirus Replication

Duchon, A. A., & Musier-Forsyth, K. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00012-1 · Cited by 1